期刊文献+

纳米药物递送系统的细胞药代动力学研究进展 被引量:6

Research progress in cellular pharmacokinetics of nano-drug delivery systems
原文传递
导出
摘要 纳米药物递送系统(nano-DDS)具有缓控释、靶向等诸多优点,是新型药物递送系统研究的热点。传统宏观的药代动力学有时难以真实有效地预测体内药物的药效,迫切需要将传统的药代动力学研究拓展到细胞/亚细胞水平,进行细胞药代动力学研究。对nano-DDS细胞药代动力学的研究有助于更全面地阐明其在细胞中的作用机制,指导nano-DDS的设计与开发。本文主要总结了nano-DDS细胞药代动力学的研究内容和研究方法,为nano-DDS的前期设计提供重要的参考依据。 Nano-drug delivery systems(nano-DDS) are the hotspots of new drug delivery systems, which have many advantages, such as sustained and controlled release, targeting delivery. Traditional pharmacokinetics are difficult to predict the efficacy of drugs in vivo sometimes. It is urgently needed to extend the traditional pharmacokinetics studies to the cell/subcellular level and perform cell pharmacokinetic studies. The study on the pharmacokinetics of nano-DDS helps us to elucidate the mechanism of the actions of them in cells and guides us to design and develop nano-DDS more reasonably. This article summarizes the research content and methods on the cellular pharmacokinetics of nano-DDS, in order to provide an important reference for the early stage design of nano-DDS.
作者 王兴 王瑶琪 张强 易崇勤 王学清 WANG Xing;WANG Yao-qi;ZHANG Qiang;YI Chong-qin;WANG Xue-qing(School of Pharmaceutical Sciences,Peking University,Beijing 100191,China;Founder Medical Research Institute Co.,Ltd.,Beijing 102206,China)
出处 《药学学报》 CAS CSCD 北大核心 2018年第10期1620-1629,共10页 Acta Pharmaceutica Sinica
基金 北京市自然科学基金资助项目(7162108)
关键词 纳米药物递送系统 细胞药代动力学 分析方法 nano-drug delivery system cellular pharmacokinetics analytical method
  • 相关文献

参考文献3

二级参考文献41

  • 1张小滨,金义光,谢英,徐昆,侯新朴.RMP-7及其衍生物对脂质体跨血脑屏障作用的影响[J].药学学报,2003,38(11):867-870. 被引量:10
  • 2Yuan F, Leunig M, Huang SK, et al.Microvascular permeability and interstitial penetration of sterically stabilized (stealth)liposomes in a human tumor xenograft[J]. Cancer Res, 1994,54(13) :3352 -3356. 被引量:1
  • 3Ceh B, Winterhalter M, Frederik P, et al. Stealth liposomes: from theory to product [ J]. Adv Drug Deliv Rev, 1997,24(2) :165 - 177. 被引量:1
  • 4Lopes de Menezes DE, Pilarski LM, Allen TM. In vitro and in vivo targeting ofimmunoliposomal doxorubicin to human B-cell lymphoma [J]. Cancer Res, 1998, 58(15) :3320-3330. 被引量:1
  • 5Moreira JN, Gaspar R, Allen TM. Targeting stealth liposomes in a murine model of humansmall cell lung cancer [ J ]. Boichim Biophys Acta, 2001,1515 ( 2 ):167 - 176. 被引量:1
  • 6Gabizon A, Shmeeda H, Horowitz AT, et al. Tumor cell targeting of liposome- entrappeddrugs with phospholipidanchored folic acid-PEG conjugates [J]. Adv Drug Deliv Rev,2004,56(8) :1177 - 1192. 被引量:1
  • 7Ruoslahti E. RGD and other recognition sequences for integrins [J]. Annu Rev Cell DevBiol, 1996,12:697 -715. 被引量:1
  • 8Matsumoto T, Numata M, Anada T, et al. Chemically modified polysaccharide schizophyllanfor antisense oligonucleotides delivery to enhance the cellular uptake efficiency [ J ].Biochim Biophys Acta, 2004,1670 ( 2 ):91 - 104. 被引量:1
  • 9Kurohane K, Namba Y, Oku N. Liposomes modified with a synthetic Arg-Gly-Asp mimeticinhibit lung metastasis of B16BL6 melanoma cells [ J ]. Life Sci, 2000,68 ( 3 ):273 - 281. 被引量:1
  • 10Haran G, Cohen R, Bar LK, et al. Transmembrane ammonium sulfate gradient in liposomesproduce efficient and stable entrapment of amphipathic weak bases [ J ].Biochim BiophysActa, 1993,1151(2) :201 -215. 被引量:1

共引文献33

同被引文献58

引证文献6

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部